Finally, patient A09 had the largest lesion size with carcinoma in situ, probably providing more severe immunosuppressive microenvironment by which the effector function of vaccine-induced systemic CD8 T cells could be thwarted. The gene discussed is CD8A; the disease is in situ carcinoma.